
Kurapwa kweMetastatic Non-Small Cell Lung CancerChinyorwa ichi chinopa mucherechedzo wakadzama wenzira dzekurapa dzemetastatic isiri diki cell lung cancer (NSCLC), kusanganisira chemotherapy, yakanangwa therapy, immunotherapy, uye radiation therapy. Isu tinoongorora kufambira mberi kwazvino uye kufunga pakusarudza chirongwa chekurapa chakanyanya chinoenderana nemurwere wega wega. Mashoko aya ndeezvinangwa zvekudzidzisa chete uye haafanire kutorwa sezano rekurapa. Gara uchitaurirana nemutarisiri wako wehutano kuti uwane nhungamiro yemunhu.
Metastatic isiri-diki cell cancer yemapapu (NSCLC) inoitika apo masero egomarara kubva mumapapu akapararira kune dzimwe nhengo dzemuviri. Ichi chirwere chakakomba chinoda nzira yakawanda yekurapa. Iyo chaiyo nzira yekurapa inotsamira pazvinhu zvakati wandei, kusanganisira mhando uye nhanho yegomarara, hutano hwemurwere hwese, uye nzvimbo yemametastases. Kukurumidza kuongororwa uye kurapwa kwakakodzera kwakakosha pakuvandudza mhedzisiro.
Chemotherapy inowanzoshandiswa kurapwa metastatic isiri-diki cell cancer yemapapu, kushandisa mishonga kuuraya masero egomarara. Kune akasiyana chemotherapy regimens, uye sarudzo inoenderana nezvinhu zvakasiyana, senge hutano hwemurwere uye nerudzi rweNSCLC. Kazhinji chemotherapy mishonga inoshandiswa inosanganisira cisplatin, carboplatin, paclitaxel, uye docetaxel. Migumisiro inogona kusiyana asi kazhinji inosanganisira kusvotwa, kuneta, uye kurasikirwa nebvudzi. The National Cancer Institute inopa ruzivo rwakadzama nezve chemotherapy regimens yeNSCLC.
Targeted therapy inoshandisa mishonga inonyatso kunanga maseru egomarara ane mamwe genetic mutations. Aya marapirwo anonyanya kushanda muvarwere vane NSCLC vanochengeta chaiyo genetic shanduko, seEGFR, ALK, ROS1, kana BRAF mutations. Mienzaniso yemishonga inonangwa yekurapa inosanganisira osimertinib (Tagrisso), crizotinib (Xalkori), uye afatinib (Gilotrif). Kunyange zvazvo kurapa kwakanangwa kunobudirira, kunogonawo kutungamirira kumigumisiro yakaipa, yakadai sokupunduka kweganda, manyoka, uye zvinetso zvechiropa. Kuongororwa kweGenetic kwakakosha kuona varwere vangangobatsirwa nekurapa kwakanangwa.
Immunotherapy inoshandisa immune system yemuviri kurwisa cancer maseru. Mishonga iyi iri kuwedzera kukosha mukurapa kwe metastatic isiri-diki cell cancer yemapapu. Immune checkpoint inhibitors, senge pembrolizumab (Keytruda) uye nivolumab (Opdivo), inovhara mapuroteni anodzivirira immune system kurwisa maseru ekenza. Ndichiri kupa mhinduro dzinoshamisa mune vamwe varwere, immunotherapy inogona zvakare kuve nemhedzisiro, kusanganisira kuneta, mapundu, uye kuzvimba. Iko kukodzera kwe immunotherapy kunoenderana nezvinhu zvakaita sePD-L1 kutaura uye tumor mutational mutoro.
Radiation therapy inoshandisa mwaranzi ine simba guru kuuraya maseru egomarara. Inogona kushandiswa kurapa mametastases emunharaunda kana kuderedza zviratidzo zvinokonzerwa nekenza, zvakadai sekurwadziwa kana kuoma kwekufema. Mhando dzakasiyana dzekurapa nemwaranzi dziripo, kusanganisira yekunze beam radiation uye brachytherapy. Maside effects eradiation therapy anogona kusanganisira kushatirwa kweganda, kuneta, uye kusvotwa.
Kusarudza chirongwa chakanyanya chekurapa che metastatic isiri-diki cell cancer yemapapu zvinoda kunyatsoongororwa zvinhu zvakawanda. Izvi zvinosanganisira hutano hwemurwere hwese, chimiro chekushanda, nhanho uye maitiro egomarara, uye kuvapo kwechero genetic mutations. Chikwata chakasiyana siyana chemaoncologists, radiologists, vanachiremba vekuvhiya, uye vamwe vashandi vehutano vanowanzo batana kugadzira chirongwa chemunhu chekurapa.
Iyo Shandong Baofa Cancer Research Institute (https://www.baofahospital.com/) yakatsaurirwa kupa hutano hwepamusoro hwegomarara uye tsvagiridzo, uchishandisa tekinoroji yekucheka-cheka uye nzira yekubatana yekuunza mhedzisiro yemurwere. Ivo vanopa akazara ekuongorora uye ekurapa masevhisi emhando dzakasiyana dzegomarara, kusanganisira metastatic isiri-diki cell cancer yemapapu.
Tsvagiridzo inoenderera mberi nekufambisira mberi kunzwisisa uye kurapwa kwe metastatic isiri-diki cell cancer yemapapu. Mitsva inonangwa yekurapa, immunotherapies, uye musanganiswa wayo inogara ichigadzirwa uye kuongororwa mumakiriniki ekuedzwa. Kufambira mberi uku kunopa tariro yekuvandudzwa kwemhedzisiro yekurapa uye nekusimudzira hupenyu hwevarwere.
Disclaimer: Ruzivo urwu nderwezvinangwa zvekudzidzisa chete uye harufanirwe kutorwa sezano rekurapa. Gara uchitaurirana nemutarisiri wako wehutano kuti uwane nhungamiro yakasarudzika maererano nemamiriro ako chaiwo.
p>
parutivi>
body>